Those receiving 1 mg of semaglutide saw an average reduction of 5.7 kg (about 12.5 pounds) of body weight
Symptoms of hypoglycaemia (low blood sugar) such as sweating, dizziness, confusion, or shakiness require immediate attention, especially if you are taking insulin or sulfonylurea medications alongside Wegovy, as these combinations increase hypoglycaemia risk
The FDA has advised that there could be health risks of taking ipamorelin due to the lack of research on the peptide, with little known about dosing in humans or its impact to humans
Competitive athletes may be subject to anti-doping rules
Other targets/mechanisms must therefore be considered
Conclusion Choosing between Zepbound or Wegovy depends on your health goals, body response, budget, and medical history